HK Stock Market Move | After the performance, LI NING (02331) opened nearly 8% higher. Revenue increased by 3.2% to 29.598 billion over the 25 years. The company continues to expand its brand influence.
Li Ning (02331) opened nearly 8% higher after its performance, with a 7.85% increase as of the time of publication, trading at 21.3 Hong Kong dollars with a turnover of 1351.49 million Hong Kong dollars.
Li-Ning (02331) opened nearly 8% higher after the performance results, and as of publication, it was up 7.85% at HK$21.3 with a trading volume of HK$1351.49 million.
On the news front, on March 19, Li-Ning announced the audited comprehensive performance results for the year ended December 31, 2025. The Group's revenue reached RMB 29.598 billion in 2025, an increase of 3.2% compared to the same period in 2024. Gross profit was RMB 14.489 billion, up 2.4% from the same period in 2024, with the Group's overall gross profit margin at 49.0%. The net profit attributable to equity shareholders for the year was RMB 2.936 billion, with a net profit margin of 9.9% and a return on equity of 10.9%. Basic earnings per share were RMB 1.1391.
The Group continues to focus on its six core categories of running, basketball, training, badminton, table tennis, and sports casual, and seizes opportunities in emerging areas such as outdoor, tennis, and pickleball. Throughout the year, the Group has continued to enhance its products through technological innovation, increase resources in professional sports, and conduct multi-dimensional marketing activities to enhance brand recognition and expand its influence.
It is worth mentioning that during the year, Li-Ning opened the world's first "Dragon Store" and launched the "Glory Gold Label" series of products, transforming top scarce sports resources into brand reputation and market recognition. This continuous effort strengthens consumer perception of Li-Ning's professional capabilities and product reliability.
Related Articles
CF PHARMTECH (02652) expects to achieve a adjusted net profit of approximately 30-35 million yuan in 2025, with stable business operations and continuous progress in innovative research and development.

US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.
CF PHARMTECH (02652) expects to achieve a adjusted net profit of approximately 30-35 million yuan in 2025, with stable business operations and continuous progress in innovative research and development.
US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


